Literatuur en richtlijnen

Literatuur

1. Lurain JR et al. Single-agent methotrexate chemotherapy for the treatment of non-metastatic gestational trophoblast tumors. Am J Obstet Gynecol 1995; 172:574
2. Covens A et al. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia. Cancer 2006; 107(6):1280-6
3. McNeish IA Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002 Apr 1; 20(7):1838-44
4. Chapman- Davis E et al. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy. Gynecologic Oncology 2012; 125:572-575
5. Bower M et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 1997; 15:2636
6. Newlands ES et al. Etoposide and cisplatin/etoposide, methotrexate and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA / cyclophosphamide and vincristine chemotherapy and patients presenting with metastaic placental site trophoblastic tumors. J Clin Oncol 2000; 18:854

Richtlijnen

Ga naar de richtlijn Trofoblastziekten in de FMS richtlijnen­database.